PMV Pharmaceuticals reports FY results

• PMV Pharmaceuticals press release (NASDAQ:PMVP): Net loss for the year ended December 31, 2023, was $69 million compared to $73.3 million for the year ended December 31, 2022.

More on PMV Pharmaceuticals

• PMV to focus on lead drug, slashes workforce by 30%
• Ladenburg Thalmann starts PMV Pharmaceuticals at buy